Back to Journals » Infection and Drug Resistance » Volume 11

Original Research

Defining the potency of amikacin against Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii derived from Chinese hospitals using CLSI and inhalation-based breakpoints

       
Total article views   HTML views PDF downloads Totals
18,430 Dovepress* 13,912+ 1,421 15,333
PubMed Central* 4,518 370 4,888
Totals 18,430 1,791 20,221
*Since 25 May 2018
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 3 5

View citations on PubMed Central and Google Scholar